IPRIPR2023-00442Final Written Decision
Samsung Bioepis Co., Ltd.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 10130681.
Type
IPR
Filed
Jan 6, 2023
Instituted
Jul 19, 2023
Decided
Jun 14, 2024
Patent
Application
15471506
Inventor
George D. YANCOPOULOS
Granted
Nov 20, 2018
01
Timeline
3 milestones
2023-01-06Petition filed
2023-07-19Institution
2024-06-14Terminated
02
Parties & counsel
Petitioner
Samsung Bioepis Co., Ltd.
Counsel
Nimrod, Raymondet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Fishman, Deborahet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →